Mixing of 2 COVID-19 vaccines not permissible for first and second dose: Centre tells Delhi HC Adity Saha28 Jan 2023 12:30 PM ISTNew Delhi: In response to the petitioner's request for permission to receive Covaxin as the second dose of COVID-19 vaccination instead of Covishield,...
Health Ministry shocker in RTI reply: CDSCO, ICMR admit to multiple side effects of Covid-19 jabs Farhat Nasim17 Jan 2023 2:04 PM ISTNew Delhi: In a shocking response to an RTI query, the Central Drugs Standard Control Organisation (CDSCO) and Indian Council of Medical Research...
COVID vaccine: DCGI approves market authorisation for Serum Institute Covovax as heterologous booster dose Ruchika Sharma17 Jan 2023 11:14 AM ISTCovovax is manufactured through technology transfer from Novavax.
Delhi High Court makes Bharat Biotech, Centre parties in pleas seeking details on COVID vaccine Covaxin Ruchika Sharma11 Jan 2023 2:56 PM ISTThree petitions challenging the Central Information Commission's (CIC) decision to withhold the facts on the grounds of trade secrets, intellectual...
Bharat Biotech partner Ocugen announces positive top-line data for COVID vaccine Covaxin Ruchika Sharma10 Jan 2023 12:40 PM ISTCOVAXINâ„¢ is a highly purified and inactivated vaccine that is manufactured using a vero cell manufacturing platform.
Bharat Biotech, Biological E together hold about 250 million COVID vaccine doses Ruchika Sharma28 Dec 2022 2:43 PM ISTBharat Biotech sources said the vaccine maker has more than 50 million doses of Covaxin readily available in vials, and over 200 million doses as drug...
Centre nod to Bharat Biotech nasal COVID vaccine iNCOVACC, to be availabile in private hospitals Ruchika Sharma23 Dec 2022 3:31 PM ISTiNCOVACC is a recombinant replication-deficient adenovirus vectored vaccine with a pre-fusion stabilized SARS-CoV-2 spike protein.
COVID vaccine: SII seeks DCGI nod for market authorisation of Covovax as booster dose Ruchika Sharma23 Dec 2022 2:30 PM ISTNew Delhi: The Serum Institute of India (SII) has sought the drug regulator's approval for market authorisation of its COVID-19 vaccine Covovax as a...
PGI Chandigarh to conduct joint study on Covishield and Covaxin combination Revu suresh28 Nov 2022 9:45 AM ISTChandigarh: A first-of-its kind study on Covid vaccines to understand the immunologic response, tolerability, and side effects of Covishield and...
DCGI gives nod to Bharat Biotech Intranasal 'Five Arms' COVID booster dose for restricted use Ruchika Sharma26 Nov 2022 11:30 AM ISTThe nasal vaccine can be taken after six months of the second dose. As this is non-invasive and needle-free, it becomes easy to administer.
Scientific approach followed in Covaxin approval: Govt rebuts all allegations on Bharat Biotech Covaxin hurried approval Ruchika Sharma17 Nov 2022 3:30 PM ISTNew Delhi: There have been media reports claiming that Bharat Biotech, manufacturer of the indigenous COVID-19 vaccine – Covaxin, "had to skip certain...
DCGI panel to hold discussion on intranasal "Five Arms" booster dose iNCOVACC on Nov 15: Sources Ruchika Sharma14 Nov 2022 1:30 PM ISTIt has now announced that iNCOVACC (BBV154) has received approval under Restricted Use in Emergency Situation for ages 18 and above.
